AI assistant
Sending…
Phio Pharmaceuticals Corp. — Director's Dealing 2025
May 23, 2025
35112_dirs_2025-05-23_a37bae60-44ec-4c1c-b3a7-9dbd99c07e35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phio Pharmaceuticals Corp. (PHIO)
CIK: 0001533040
Period of Report: 2025-05-21
Reporting Person: Bitterman Robert J (Director, Chairman, Pres & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-21 | Common Stock, $0.0001 par value | P | 3000 | $1.77 | Acquired | 22449 | Direct |
| 2025-05-22 | Common Stock, $0.0001 par value | P | 1200 | $1.7799 | Acquired | 23649 | Direct |
Footnotes
F1: Includes shares of common stock underlying unvested restricted stock units.
F2: The number of reported securities has been adjusted to reflect prior reverse stock splits.
More from Phio Pharmaceuticals Corp.
Board/Management Information
2026
Jul 21
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 23
Board/Management Information
2026
Feb 18
Major Shareholding Notification
2026
Feb 17
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6